RHÖN-KLINIKUM AG / Key word(s): Change of Personnel/Miscellaneous

19-Jan-2017 / 18:20 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.



Disclosure of an inside information according to Article 17 EU Market Abuse
Regulation (MAR)

Rhön-Klinikum AG: Decision Making Process of Supervisory Board  of Rhön-
Klinikum concerning Reorganization of Management Board

Bad Neustadt, 19.01.2017. There is currently a decision making process in
the supervisory board of RHÖN-KLINIKUM AG concerning a reorganization of
the management board that will be completed in this form no later than
Friday, 20 January 2017, 24:00. In case the resolution is passed, the
supervisory board would appoint Stephan Holzinger with effect as of 01
February 2017 as member of the management board. Stephan Holzinger has
already been a member of the supervisory board of RHÖN-KLINIKUM AG for a
number of years; he would resign from this position.

Together with his appointment to the management board Stephan Holzinger
would at the same time become its chairman. Dr. Dr. Martin Siebert, who has
been the chairman so far, would become vice chairman of the management
board for personal reasons.

Holzinger studied administrative sciences - an interdisciplinary curriculum
of law, economics and politics - at the universities of Konstanz and Oslo.
His professional carreer led him to US-Senator John W. Warner, Raytheon
Inc. and BMW Group. He authored various books and articles on the subject
and lectured at universities on communication strategy. High net worth
families, members of management and supervisory boards, enterprises and
entrepreneurs have relied on his advice regarding strategic reputation
management for a decade.

Through his position as member of the supervisory board of RHÖN-KLINIKUM
AG, as member of the supervisory board of the only private university
hospital in Germany  in Gießen-Marburg (UKGM) and as director of HCM S.E.
he is closely connected to the health care industry.

In connection with this reorganization individual responsibilities would be
adjusted internally. The supervisory board would finally discuss resulting
adjustments of the division of responsibilities within the management board
during its next ordinary meeting on 23. February 2016.

Your Contact:

Dr. Kai G. Klinger (disclosing person)
Investor Relations & Corporate Finance
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telefon: 09771 65-1318
Telefax: 09771 99-1736
Email: ir@rhoen-klinikum-ag.com

Achim Struchholz
Communication
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telefon: 09771 65-1327
Telefax: 09771 65-1820
E-Mail: kommunikation@rhoen-klinikum-ag.com



19-Jan-2017 CET/CEST The DGAP Distribution Services include Regulatory
Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



   Language:    English
   Company:     RHÖN-KLINIKUM AG
                Salzburger Leite 1
                97616 Bad Neustadt a.d.Saale
                Germany
   Phone:       +49 (0)9771 - 65-0
   Fax:         +49 (0)9771 - 97 467
   E-mail:      rka@rhoen-klinikum-ag.com
   Internet:    www.rhoen-klinikum-ag.com
   ISIN:        DE0007042301
   WKN:         704230
   Indices:     SDAX
   Listed:      Regulated Market in Frankfurt (Prime Standard), Munich;
                Regulated Unofficial Market in Berlin, Dusseldorf,
                Hamburg, Stuttgart, Tradegate Exchange



     End of Announcement    DGAP News Service